EGFR and non-small cell lung carcinoma: Although these were only preliminary results, they were consistent with Yamada and colleagues findings [71]: in this study, 27 patients with advanced NSCLC harbouring EGFR mutations (uncommon or T790M), progressing after a TKI treatment, were retrospectively analysed.